Positioning biologics in the treatment of IBD: A practical guide - Which mechanism of action for whom?

Juillerat, Pascal; Martinho Grueber, Maude; Ruetsch, Roseline; Santi, Giulia; Vuillèmoz, Marianne; Michetti, Pierre (2022). Positioning biologics in the treatment of IBD: A practical guide - Which mechanism of action for whom? Current research in pharmacology and drug discovery, 3(100104), p. 100104. Elsevier 10.1016/j.crphar.2022.100104

Preview

Text 1-s2.0-S2590257122000244-main.pdf - Published Version Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND). Download (1MB) | Preview

The number of available biological therapies have doubled over the last 10 years and the arrival of novel molecules (interleukin 23p19 inhibitors) is ongoing alongside the development of small molecules. As a result of this vast landscape of treatment, positioning advanced therapies (according to clinical situation, efficacy and safety) is of paramount importance to providing personalized, appropriate IBD treatment. In this publication the recent available literature is summarized for practical integration into clinical practice including comparative efficacy data, patient and disease demographics. We refer to recent publications and expert opinion in order to facilitate the decision making process of positioning biologicals IBD treatment.

Interest & Impact

Downloads

210 since deposited on 17 May 2022
110 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item